Dong, S., Wang, M., Luo, Z., Wu, W., Huang, H., Yang, J., Liang, Y., Jiang, H. and Qiu, L. (2020) “Glofitamab plus polatuzumab vedotin: a novel safe, and highly effective chemotherapy-free regimen for pediatric relapsed/refractory B-cell non-Hodgkin lymphoma”, Haematologica. Pavia, Italy. doi: 10.3324/haematol.2026.300836.